AI AI PT & Q&A AI AI PT & Q&A ( ) 1~4 1, 1 1 - 4 1 * , , ,
[0079] Advantageous skin and hair tanning active ingredients in this respect are substrates or substrate analogues of tyrosinase such as L-tyrosine, N-acetyl tyrosine, L-DOPA or L-dihydrox- yphenylalanine, xanthine alkaloids such as caffeine, theobromine and theophyl-line and de rivatives thereof, proopiomelanocortin peptides such as ACTH, alpha-MSH, peptide analogues thereof and other substances which bind to the melanocortin receptor, peptides such as Val- Gly-Val-Ala-Pro-Gly, Lys-lle- Gly-Arg-Lys or Leu-lle-Gly-Lys, purines, pyrimidines, folic acid, cop per salts such as copper gluconate, chloride or pyrrolidonate, l,3,4-oxadiazole-2-thiols such as 5-pyrazin-2-yl-l,3,4-oxadiazole-2-thiol, curcumin, zinc diglycinate (Zn(Gly)2), manganese(ll) bicarbonate complexes ("pseudocat-alases") as described for example in EP 0 584 178, tetrasubstituted cyclohexene deriva-tives as described for example in WO 2005/032501 , iso- prenoids as described in WO 2005/102252 and in WO 2006/010661 , melanin derivatives such as Melasyn-100 and MelanZe, diacyl glycerols, aliphatic or cyclic diols, psoralens, prostaglan dins and ana-logues thereof, activators of adenylate cyclase and compounds which activate the transfer of melanosomes to keratinocytes such as serine proteases or agonists of the PAR- 2 receptor, extracts of plants and plant parts of the chrysanthemum species, san-guisorba species, walnut extracts, urucum extracts, rhubarb extracts, microalgae extracts, in particular Isochrysis galbana, trehalose, erythru-lose and dihydroxyacetone
See your doctor if you have any concerns
The main factors that move the price are the type and depth of your pigmentation, your skin tone (which determines which modalities are safe), the number of sessions your case realistically needs, and whether the plan includes prescription topicals, oral support, or IV therapy alongside the in-clinic treatments
It also suppressed TGF- activation and inflammatory cytokines, thereby resulting in the breakdown of the ECM accumulation pathway [58]
